MH
Insider selling
Mark Hopman sold $12K of Beta Bionics, Inc. (BBNX) stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 775 shares of BBNX stock worth $12K, per an SEC Form 4 filed Sep 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 14, 2026, 1 day before it was made public.
BBNX has moved +6.8% since the trade date, from $16.73 to $17.86 (Oct 12, 2026 close).
- Traded
- Sep 14, 2026
- Disclosed
- Sep 15, 2026
- Filing delay
- 1 day
- Price since
- +6.8%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4
More BBNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.